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2Abstract 35 
36 The lateral habenula (LHb) encodes aversive stimuli contributing to 
37 negative emotional states during drug withdrawal. Here, we report that 
38 morphine withdrawal (MORwd) in mice leads to microglia adaptations 39 
and diminishes glutamatergic transmission onto raphe-projecting LHb 
40 neurons. Chemogenetic inhibition of this circuit promotes MORwd-like 
41 social deficits. MORwd-driven synaptic plasticity and reduced sociability 
42 require TNFα release and neuronal TNF-Receptor-1 activation. Hence, 
43 habenular cytokines control synaptic and behavioral adaptations during 
44 drug withdrawal.  
45  
46 Opiate withdrawal produces negative states including low mood and reduced 
47 sociability, contributing to relapse during drug abstinence1,2. Dysfunction of 
48 the lateral habenula (LHb) – a nucleus controlling monoaminergic systems 
49 and processing aversive stimuli – underlies depressive symptoms typical of 
50 drug withdrawal3, yet how opiates affect the LHb remains poorly known4,5. 
51  
52 We subjected mice to naloxone-precipitated MORwd to examine its 
53 repercussions on glutamatergic synapses onto LHb neurons1. Indeed, 
54 aberrant LHb excitatory transmission underlies negative symptoms in rodent 
55 models of depression and addiction3. Spontaneous excitatory postsynaptic 
56 current (sEPSC) amplitudes, but not frequencies, were reduced only in LHb 
57 neurons located in the medial aspect (MedLHb; lateral LHb, LatLHb; 
58 Supplementary Fig. 1a–b). Accordingly, MORwd diminished AMPAR:NMDAR 
59 ratios solely in MedLHb (Fig. 1a and Supplementary Fig. 1c) without affecting 
60 neurotransmitter release assessed by trains of synaptic stimulation 
61 (Supplementary Fig. 1d). Recordings obtained 1 hour after the last MOR 
62 injection (without naloxone) yielded saline-comparable AMPAR:NMDAR 
63 ratios. In contrast, spontaneous MORwd decreased AMPAR:NMDAR ratios in 
64 the MedLHb up to 30 days after the last MOR injection (Supplementary Fig. 65 
1e).  
66 
3To assess whether MORwd affects AMPAR conductance or number, we used 67 
peak-scaled non-stationary fluctuation analysis of MedLHb-recorded sEPSCs6. 68 
While single-channel conductance remained unaffected in MORwd slices, the 69 
number of channels opened at the peak positively correlated with amplitude 70 
values (Supplementary Fig. 1f). MORwd failed to alter AMPAR-EPSC 71 
rectification (Supplementary Fig. 1g), whereas it reduced glutamate uncaging-72 
evoked AMPAR:NMDAR ratios, yielding a decrease only in absolute AMPAR 73 
currents (Supplementary Fig. 1h). This suggests that MORwd reduces, in a 74 
territory-specific fashion, the number of AMPARs without affecting their 75 
biophysical properties, NMDARs or presynaptic glutamate release. 76 
 77 
MORwd-evoked plasticity occurs onto MedLHb neurons, which innervate 78 
downstream structures including the raphe nucleus and the ventral tegmental 79 
area (VTA)7. MORwd diminished AMPAR:NMDAR ratios solely in retrobeads-80 
labeled Raphe– but not VTA–projecting LHb neurons (LHbRaphe and LHbVTA) 81 
(Fig. 1b, c) pointing to its specificity for discrete habenular circuits. 82 
83  
84 Which induction mechanism gates MORwd-driven plasticity onto MedLHb 
85 neurons? Inflammatory responses and glial cell activation emerge during drug 
86 withdrawal8. Indeed, spontaneous MORwd drives microglia adaptations and 87 
pro-inflammatory cytokine release (i.e. tumor necrosis factor-α (TNFα))9. 
88 Notably, cocaine also leads to reduced microglia arborization along with 
89 TNFα-dependent AMPAR internalization, partly underlying drug-mediated 
90 behavioral adaptations8. We found that, within the MedLHb, MORwd i. reduced 
91 microglial markers including Iba1 and CD68 and ii. diminished microglial cell 
92 volume (Fig. 2a–d). In parallel, naloxone- and spontaneous MORwd 
93 increased habenular TNFα immunolabeling (Fig. 2e and Supplementary Fig. 
94 2a–d). Altogether, these findings support the engagement of inflammatory 
95 responses and cytokine signaling within the LHb during MORwd.  
96  
97 We then reasoned that if MORwd promotes TNFα release, artificially 
98 increasing its levels should prove sufficient to recapitulate MORwd-driven 99 
synaptic plasticity. Incubating LHb-containing slices from saline-injected mice 
4100 with exogenous TNFα reduced AMPAR:NMDAR ratios in the MedLHb. This 101 
effect was absent in LatLHb, and occluded by naloxone and spontaneous 
102 MORwd (Fig. 2f–g and Supplementary Fig. 3a). TNFα release may arise from 
103 microglial Toll-Like Receptor 4 (TLR-4) signaling10. Systemically activating 
104 TLR-4 with the agonist MPLA in MOR-treated mice, instead of naloxone, 
105 mimicked MORwd plasticity (Supplementary Fig. 3b). Moreover, MPLA 
106 application in slices from MOR-treated animals reduced AMPAR currents in 
107 MedLHb, but not LatLHb (Supplementary Fig. 3c–d). MPLA-driven EPSCs 
108 reduction did not occur in presence of a dominant negative peptide, which 
109 blocks the soluble form of TNFα (XENP1595; Supplementary Fig. 3e)8. 
110 Furthermore, MORwd occluded MPLA-driven synaptic depression 
111 (Supplementary Fig. 3c) and systemic injection of XENP1595 prevented 
112 MORwd-induced plasticity (Supplementary Fig. 3f). Altogether, this supports 
i. 113 TLR-4 expression within the LHb (See Allen Brain Atlas), ii. its effect on 
114 AMPARs via TNFα signaling, and iii. the necessity and sufficiency of TNFα for 
115 MORwd-driven reduction of LHb glutamatergic transmission. 
 116 
TNFα triggers its central effects partly through TNF receptor-type-1 (TNF-117 
R1)11. We employed TNF-R1fl/fl mice to Cre-dependently knock-down TNF-R1 118 
expression in LHb neurons (Fig. 3a–c). After viral injection, AAVCre-TNF-R1fl/fl 119 
mice failed to show MORwd-driven AMPAR:NMDAR ratio reduction compared 120 
to AAVControl-infused mice (Fig. 3d). This highlights the necessity of neuronal 121 
TNF-R1 for MORwd-driven depression of synaptic AMPARs in LHb. 122 
123  
124 MORwd drives negative symptoms among which social detachment1. 
125 Similarly, LHb dysfunction contributes to the negative states emerging in 
126 addiction, although its implications for sociability remains poorly addressed. 
127 We examined the contribution of the LHb-to-Raphe pathway, the locus of 
128 MORwd plasticity, for social behavior. We employed an intersectional 
129 chemogenetic approach to reduce the efficiency of the LHb-to-Raphe 
130 projection. This combined the retrograde expression of cre-recombinase 
131 (HSV-Cre, dorsal raphe) with cre-dependent expression of hM4Di (rAAV- 
132 hM4Di-mCherry, DREADDi, LHb; Fig. 3e). Reducing LHb-to-Raphe efficiency 
5133 with clozapine-N-oxide diminished social preference (Fig. 3f), supporting LHb 
134 contribution to social behaviors. 
135 Next, we recapitulated MORwd-driven reduction in social preference in 
136 C57Bl6 mice (Fig. 3g and Supplementary Fig. 4a–d). We then prepared slices 
137 from MORwd mice showing low or high sociability scores, and found that 
138 MedLHb AMPAR:NMDAR ratios positively correlated with the social score (Fig. 
139 3h). This indicates that reduced synaptic strength in the LHb predicts opiate- 
140 WD-driven sociability deficits.  
141 Notably, microglia and TNFα signaling also contributes to social behaviors12. 
142 Accordingly, MORwd-driven sociability deficits were absent after cre-
143 dependent LHb TNF-R1 knock-down (Fig. 3i and Supplementary Fig. 4e–i). 
144 This genetic intervention did not affect locomotion (Supplementary Fig. 4j). 
 145 
We found that MORwd-driven TNFα release requires neuronal TNF-R1 to 146 
reduce AMPAR transmission onto raphe-projecting, medially-located, LHb 147 
neurons. This ultimately gates MORwd-driven social impairment, a negative 148 
symptom typical of opiate withdrawal.  149 
150  
151 Together with sociability deficits, MORwd also leads to anxiety and 
152 hyperalgesia1. Since the contribution of LHb on these two behavioral aspects 
153 remains elusive we cannot rule out that MORwd-driven habenular plasticity is 
154 specific for withdrawal-mediated sociability defects.  
155 The TNFα-TNF-R1 engagement within the LHb represents a previously 
156 unidentified mechanism underlying precise cellular and behavioural aspects 
of 157 MORwd. Yet this is consistent with the following: i. drugs and drug-
158 withdrawal-mediated modulation of AMPAR transmission partly rely on 
159 cytokine signaling8; ii. inhibition of TLR-4 attenuates MORwd symptoms13; iii. 
160 TNF-Rs contribute to social behaviors14. Notably, in pyramidal neurons of the 
161 hippocampus and cortex, TNFα regulates AMPAR surface expression15,16. 
162 This phenomenon is opposite at striatal synapses where, similarly to the LHb, 
163 TNFα application results in decreased AMPAR transmission8. This divergence 
164 may arise from different TNFα release dynamics, TNF receptors expression 
165 and signaling, or alternatively AMPAR anchoring properties within the LHb. 
6166 MORwd modifies the morphology of microglia in the LHb. This is, at least 
167 partly, consistent with previous findings8, yet it remains correlative with 
168 respect to TNFα levels. This heightens the need to fill the gap in 
169 understanding microglia function and its relationship with TNFα within the 
170 habenula. Overall, while pharmacotherapies targeting pro-inflammatory 
171 pathways in substance abuse are missing, our data support cytokine 
signaling 
172 as a cellular pillar for aspects of drug addiction. 3  
174 MORwd-driven TNFα-dependent depression of AMPAR transmission occurs 
175 at LHbRaphe neurons. From a circuit standpoint, this may provide an ‘anti- 
176 social’ signal likely through reduced actions onto raphe neuronal populations. 
177 This is consistent with the evidence reported here that chemogenetic 
178 manipulation of the LHb-to-Raphe projection diminishes sociability. Alongside, 
179 dopamine- and serotonin-containing raphe neurons contribute to social 
180 behaviors, and medially-located LHb neurons monosynaptically connect to the 
181 latter17–19. Understanding the repercussions of LHb activity onto raphe 
182 neuronal subtypes during MORwd remains an important aspect for future 
183 investigation.   
 184 
In conclusion, our data support the participation of cytokine-mediated 185 
plasticity for opiate-evoked negative symptoms, a mechanism by which LHb 186 
ultimately contributes to the addiction spiral. 187 
 188 
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Figure legends 282 
Figure 1 MORwd-driven projection-specific synaptic depression in LHb.  283 
(a) Naloxone-precipitated MORwd (NP-MORwd) protocol and 284 
AMPAR:NMDAR ratios from LatLHb (saline+naloxone (nmice/cells=7/11; gray) 285 
versus NP-MORwd (nmice/cells=8/11; orange): two-sided t-test, t20=0.0548, 286 
P=0.957) and MedLHb: (saline+naloxone (nmice/cells=7/12; black) versus NP-287 
MORwd (nmice/cells=8/13; red): two-sided t-test, t23=2.210, *P=0.037) (b) 288 
Retrobeads in Raphe (left) and retrogradely-labeled LHbRaphe neurons (right) 289 
images. AMPAR:NMDAR ratios from LHbRaphe neurons (saline+naloxone 290 
(nmice/cells=5/10; black) versus NP-MORwd (nmice/cells=5/11, red), two-sided t-291 
test, t19=3.153, **P=0.005). (c) Same as c but in VTA (saline+naloxone 292 
(nmice/cells=2/6; black) versus NP-MORwd (nmice/cells=4/7; red), two-sided t-test, 293 
t11=0.575, P=0.577). Sal, saline; Mor, morphine; Nlx, naloxone; PAG, 294 
periaqueductal gray; DG, dentate gyrus; MHb, medial habenula; SNr, 295 
substantia nigra pars reticulata. Data are presented as box plots 10-90 296 
percentiles with median and scatter.  297 
 298 
Figure 2 Cytokine signaling in the LHb for MORwd plasticity. 299 
(a) Max-projection of confocal acquisition of LHb of Iba1-positive microglia 300 
(left). Max-projection of MedLHb microglia in saline+naloxone and NP-MORwd 301 
mice (top right). 3D reconstruction of Iba1 positive microglia, containing CD68 302 
structures in saline+naloxone and NP-MORwd (bottom right). (b) Analysis of 303 
Iba1 microglia immunoreactivity in MedLHb (Saline+naloxone (black) 304 
nmice/cells=4/366, NP-MORwd (red) nmice/cells=4/328, two-sided t-test, t692=3.305, 305 
***P=0.001; three independent acquisition sessions). (c, d) Quantitative 306 
analysis of microglial cell volume (based on Iba1-immunoreactivity) and 307 
CD68-positive structures. Values are normalized to Saline control 308 
(Saline+naloxone (black) nmice/cells=4/89, NP-MORwd (red) nmice/cells=4/83; Iba1 309 
volume, two-sided t-test, t170=3.05, **P=0.003; CD68/Iba1 volume, two-sided 310 
t-test, t170=2.65, **P=0.008). Measurements were obtained from independent 311 
samples. (e) TNFα(cyan) and DAPI (magenta) immunostaining  and 312 
normalized TNFα optical density in the LHb (saline+naloxone (nmice=7; 6 313 
independent acquisitions/mouse; black) versus NP-MORwd (nmice=8; red; 5 314 
  11
independent acquisitions/mouse), two-sided t-test, t13=2.991, *P=0.0104). (f) 315 
Experimental protocol and AMPAR:NMDAR ratios in LatLHb without (–) or with 316 
(+) exogenous TNFα (saline+naloxone (–) TNFαnmice/cells=2/9;  vs 317 
saline+naloxone (+)TNFα nmice/cells=2/9; lighter gray: two-sided t-test, 318 
t14=0.37,  P=0.717). (g) AMPAR:NMDAR ratios without (–) or with (+) 319 
exogenous TNFα from saline+naloxone (black, nmice/cells=3/10 320 
and gray, nmice/cells=4/11) and NP-MORwd MedLHb slices (red, nmice/cells=3/10 321 
and pink, nmice/cells=5/15) (interaction factor F(1, 42)=4.90 two-way ANOVA, 322 
*P=0.039). Data are presented as box plots 10-90 percentiles with median 323 
and scatter.  324 
 325 
Figure 3 TNFR1 requirements for MORwd-driven synaptic and 326 
behavioural adaptations. 327 
(a) Experimental protocol. (b) Image and (c) quantification of AAV-Cre-328 
infected LHb neurons (magenta) and total LHb neurons (cyan; 3 mice: M1, M2 329 
and M3). (d) AMPAR:NMDAR ratios from MedLHb of: AAVControl-TNF-R1fl/fl 330 
(saline+naloxone (nmice/cells=2/9; gray) versus NP-MORwd (nmice/cells=3/14; 331 
red)) or AAVCre-TNF-R1fl/fl (saline+naloxone (nmice/cells=4/13; open gray) versus 332 
NP-MORwd (nmice/cells=3/12; open pink)) (interaction factor F(1,44)=4.887 two-333 
way ANOVA, *P=0.032). (e) AAV-Control or AAV-Flex-DREADDi virus 334 
injections in the LHb and HSV-Cre virus in the Raphe. (f) Tracking, box and 335 
scatter plots of social preference test (SPT) in C57Bl6 mice expressing or not 336 
DREADDi in LHb-to-raphe neurons (Control virus (black) versus DREADDi 337 
(red), nmice=8/group, t18=2.271, *P=0.043). (g) Tracking plots of social 338 
preference test (SPT) in C57/Bl6 mice. Box/scatter plots showing social 339 
preference score (saline+naloxone (black) versus NP-MORwd (red), nmice=22 340 
/group, t42=2.559, *P=0.014). Full circles indicate mice used for recordings in 341 
h. (h) Correlation of AMPAR:NMDAR ratios and social preference score 342 
(nmice/cells=4/12 ; Pearson’s r2= 0.954; *P=0.023). Shaded circles represent 343 
single cell, full circles represent average per mouse (mean and sem). (i) 344 
Tracking and box/scatter plots of SPT in TNF-R1fl/fl mice (AAVControl: 345 
saline+naloxone (nmice=20; black), NP-MORwd (nmice=20; red), AAVCre: 346 
saline+naloxone (open gray), NP-MORwd (open pink), nmice=13 mice/group, 347 
  12
interaction factor F(1, 65)= 7.20 two-way ANOVA, **P=0.009). S, social 348 
stimulus; O, object. Data are presented as box plots 10-90 percentiles with 349 
median and scatter.  350 
 351 
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Methods 353 
Animals and morphine treatments. C57Bl/6J wild-type (male) and 129-354 
Tnfrsf1atm3GkI (male and female, referred as TNF-R1fl/f) mice of 4–10 weeks 355 
were group-housed (three to five per cage) on a 12:12 h light cycle (lights on 356 
at 7 a.m.) with food and water ad libitum. All procedures aimed to fulfill the 3R 357 
criterion and were approved by the Veterinary Offices of Vaud (Switzerland; 358 
License VD3172). Part of the current study was carried out in the Institut du 359 
Fer a Moulin, Paris and experiments were in accordance with the guidelines 360 
of the French Agriculture and Forestry Ministry. Morphine withdrawal was 361 
either precipitated with naloxone or was induced naturally. For naloxone-362 
precipitated morphine withdrawal, mice were subjected to six-day 363 
intraperitoneal (i.p.) morphine (20mg/kg, Cantonal Hospital of Lausanne, 364 
CHUV, Switzerland) or saline injections (saline and morphine-treated animals 365 
were housed together). On day 6, the last morphine/saline injection was given 366 
in a separate cage, thirty minutes after which animals received an i.p. injection 367 
of naloxone hydrochloride (2mg/kg, Abcam). Morphine withdrawal 368 
dependence symptoms were allowed to develop in the following thirty 369 
minutes, after what mice were either sacrificed for ex vivo electrophysiological 370 
recordings or were subjected to behavioral tests.  371 
 372 
For spontaneous withdrawal, mice were treated with morphine or saline for 6 373 
days and were sacrificed for recordings 10-13, 20 or 30 days after the last 374 
injection. For recordings in morphine-treated animals not in withdrawal, mice 375 
were sacrificed one hour after the last morphine injection on day 6. To assess 376 
TNFα involvement in morphine withdrawal plasticity, part of the animals were 377 
subjected to an i.p. injection of MPLA (Monophosphoryl Lipid A, 10 g, a Toll-378 
like receptor 4 activator dissolved in DMSO and saline) or saline (containing 379 
the same amount of DMSO as control)8 instead of naloxone thirty minutes 380 
after the last morphine injection on day 6. Another portion of the animals 381 
received an i.p. injection of a dominant negative peptide blocking the soluble 382 
form of TNFαXENP1595, 30mg/kg, Xencor, US)8 one hour prior the last 383 
morphine or saline injection on day 6. Thirty minutes after the morphine/saline 384 
injection these animals received naloxone and were sacrificed for recordings 385 
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as described above. No statistical methods were chose to pre-determine 386 
sample sizes but our sample sizes are similar to those reported previously6. 387 
 388 
Surgery. Animals of at least 4 weeks were anesthetized with ketamine (150 389 
mg/kg)/xylazine (100 mg/kg) i.p. (Veterinary office University of Lausanne) 390 
and were placed on a stereotactic frame (Kopf, Germany). Bilateral injections 391 
of 200-400 nl volume were performed through a glass needle, at a rate of 392 
approximately 100 nl min−1. The injection pipette was withdrawn from the 393 
brain 10 min after the infusion. Retrobeads (Lumafluor) were infused into the 394 
dorsal raphe nucleus (A-P:-3.5; M-L:0;D-V:-3.8 mm) or ventral tegmental area 395 
(A-P:-2.4; M-L:±0.65;D-V:-4.9 mm) of C57Bl6 mice. 129-Tnfrsf1atm3Gki mice 396 
were injected with either rAAV2-hSyn-eGFP or rAAV2-hSyn or CMV-Cre-397 
eGFP into the LHb (A-P:-1.35; M-L: ±0.45;D-V:-3.00 mm). In another set of 398 
experiments C57Bl6 mice were injected with a herpes simplex virus derived 399 
hEF1α-cre vector (MGA Gene delivery technology core, Cambridge, MA, 400 
USA) in the raphe nucleus and with rAAV-DJ-EF1-Flex-hM4D(Gi)-mCherry 401 
(Gene vector and virus core, Stanford medicine, CA, USA) in the LHb. 402 
Animals were allowed to recover for about 5-7 days after retrobeads injections 403 
or 5 weeks after viral infusion before being submitted to morphine/saline 404 
treatment. The injection sites were carefully examined for all electrophysiology 405 
experiments and only animals with correct injections were used for 406 
recordings. Similarly, for behavioral studies only animals with correct injection 407 
sites were included in the analysis. Brain slices from mice injected with 408 
retrobeads or viruses were directly examined under an epifluorescence 409 
microscope. 410 
 411 
Ex-vivo electrophysiology. Animals of 5 weeks were anesthetized with 412 
ketamine/ xylazine; 150 mg/kg/100 mg/kg i.p. for preparation of LHb-413 
containing brain slices. Slicing was done in bubbled ice- cold 95% O2/5% 414 
CO2-equilibrated solution containing (in mM): choline chloride 110; glucose 415 
25; NaHCO3 25; MgCl2 7; ascorbic acid 11.6; sodium pyruvate 3.1; KCl 2.5; 416 
NaH2PO4 1.25; CaCl2 0.5. Coronal slices (250 μm) were prepared and 417 
transferred for 10 min to warmed solution (34 °C) of identical composition, 418 
before they were stored at ~22 °C in 95% O2/5% CO2-equilibrated artificial 419 
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cerebrospinal fluid (ACSF) containing (in mM): NaCl 124; NaHCO3 26.2; 420 
glucose 11; KCl 2.5; CaCl2 2.5; MgCl2 1.3; NaH2PO4 1. Recordings (flow 421 
rate of 2.5 ml/min) were made under an Olympus-BX51 microscope 422 
(Olympus) at 32 °C. Patch-clamp experiments were performed using 423 
borosilicate glass pipettes (2.7–4 MΩ; Phymep, France). Currents were 424 
amplified, filtered at 5 kHz and digitized at 20 kHz (Multiclamp 200B; 425 
Molecular Devices, USA). Data were acquired using Igor Pro with NIDAQ 426 
tools (Wavemetrics, USA). Access resistance was monitored by a step of −4 427 
mV (0.1 Hz). Experiments were discarded if the access resistance increased 428 
more than 20%. All recordings were made in voltage-clamp configuration. 429 
Spontaneous EPSCs were recorded either in the lateral or in the medial 430 
territory of the LHb at −60 mV in presence of picrotoxin (100 μM, Abcam) and 431 
APV (50 μM, Abcam). The internal solution contained (in mM): CsCl 130; 432 
NaCl 4; MgCl2 2; EGTA 1.1; HEPES 5; Na2ATP 2; sodium creatine-433 
phosphate 5; Na3GTP 0.6; spermine 0.1. The liquid junction potential was −3 434 
mV and was not compensated. For AMPAR:NMDAR ratios EPSCs were 435 
evoked through glass electrodes placed ~200 μm from the recording site 436 
using AMPI ISO-Flex stimulator. A mixture of AMPA and NMDA currents were 437 
evoked at +40 mV (in presence of picrotoxin). The two components were 438 
pharmacologically isolated by adding APV in the recording solution and by 439 
subsequent identification of the individual currents via digital subtraction. For 440 
glutamate uncaging experiments MNI-glutamate (4-methoxy-7-nitroindolinyl-441 
caged L-glutamate 500µM, Tocris) was added to the recording solution. 442 
Uncaging was obtained via a single-path photolysis head (Prairie 443 
Technologies) connected to a solid-state laser (Rapp Optolectronics, 444 
Germany; 405 nm, duration 1 ms, diameter 3–5µm, 250-300μm from soma).  445 
AMPAR:NMDAR ratios in uncaging experiments were calculated as follows: 446 
AMPA-EPSC at −60 mV/NMDA-EPSCs at +40 mV and the individual 447 
components were identified as previously described, using the late 448 
component of the EPSC at 30 ms after the onset. Rectification index was 449 
computed by recording AMPA-EPSC at −70 and +40 mV and was calculated 450 
as follows: (AMPA-EPSC at −70/AMPA-EPSC at +40)/1.75. To assess 451 
presynaptic release properties, trains of AMPAR-EPSCs were evoked using 452 
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extracellular stimulating electrode (5 pulses at 5Hz, 10Hz and 20Hz). The 453 
amplitudes of EPSCs trains were normalized to the amplitude of the first 454 
pulse. When indicated recordings were performed from retrogradely labeled 455 
and fluorescently identified LHb neurons. Some experiments were performed 456 
in LHb-containing slices incubated for minimum one hour with exogenous 457 
TNFα (100ng/ml). To test the effect of MPLA on AMPAR transmission, 458 
neurons were patched either in the lateral or the medial territory of the LHb 459 
and EPSCs were evoked with extracellular stimulation. Following a ten-minute 460 
baseline, MPLA (1g/ml) was added to the recording solution and EPSCs 461 
were recorded minimum 40 minutes after. Some experiments were performed 462 
in presence of the TNFαdominant negative peptide 6mg/1ml; 463 
XENP1595, Xencor, US) in the recording solution.  464 
 465 
Non stationary fluctuation analysis. 466 
A peak-scaled nonstationary fluctuation analysis (NSFA) was performed on 467 
sEPSCs (# of events, 70–250) (Synaptosoft, USA). sEPSCs were selected 468 
by: fast rise time alignment, stable baseline holding current, and the absence 469 
of spurious fluctuations during the sEPSCs decay. The variance–amplitude 470 
relationship of sEPSC decay was plotted and fitted with the equation 471 
σ2 = iI − I2/N + σb2 (where i is the mean single-channel AMPA current, I is the 472 
mean current, N is the number of channels activated at the peak, N = mean 473 
amplitude/i; and σ2 is the baseline variance). i was estimated as the slope of 474 
the linear fit of the first portion of the parabola of the fitted sEPSC decay. The 475 
goodness-of-fit was assessed with a least-squares algorithm. The unitary 476 
current was converted in conductance based on the reversal potential of 477 
evoked EPSCs (0 mV) and the holding potential (–60 mV). Conductance and 478 
average EPSC amplitude, mean rise time, mean decay time, access 479 
resistance, or background noise variance had no correlation (p > 0.4). 480 
 481 
Histology and immunofluorescence. Mice were injected daily with 482 
saline/morphine (20mg/kg, i.p.) for 6 days. Some mice were left to develop 483 
spontaneous withdrawal, while others received naloxone (2mg/kg, i.p.) 484 
injection 30 min after the last saline/morphine injection on day 6. After 10-13 485 
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days of spontaneous withdrawal or 30 min after naloxone injection mice were 486 
anhestetized and perfused with cold 4% paraformaldehyde (PFA) in PBS 487 
(phosphate-buffered saline). The brains were extracted, post-fixed in 4% PFA 488 
in PBS, and incubated in 30% sucrose in PBS until they sank. 30 µm slices 489 
were cut at the cryostat, and stored in PBS containing 0.02% NaN3 for future 490 
analysis. For the immunofluorescence, the slices were incubated 2h in 491 
blocking buffer (5% NGS, 0.3% Triton-X in PBS) and then 24h at 4°C with the 492 
primary antibody solution (mouse anti-TNFα antibody, ab1793, Abcam, 1:100 493 
in blocking buffer8). After extensive rinses, the secondary antibody was 494 
applied (goat anti-mouse IgG-conjugated Alexa 488, Invitrogen, 1:400 in 495 
blocking buffer, 24h at 4°C). The slices were then incubated in a 1:400 DAPI 496 
solution in PBS, extensively rinsed, mounted on glass slides with Pro-Long 497 
Gold Antifade Reagent (Invitrogen) and coverslipped. Images were acquired 498 
with an epifluorescent microscope with a 20x objective (AxioVision, Zeiss) 499 
using the same parameters for all the samples. The images were analyzed 500 
and processed with ImageJ software. Optical density was measured on the 501 
whole LHb area, and normalized on the neighboring thalamus [LHb-502 
Thal/(LHb+Thal)]. 3-6 slices distributed in the rostrocaudal axis were analyzed 503 
per each animal (8 morphine, 7 saline). 504 
 505 
Microglia analysis 506 
Mice were anhestetized and perfused with cold 4% paraformaldehyde (PFA) 507 
in PBS (phosphate-buffered saline). The brains were extracted, post-fixed in 508 
4% PFA in PBS, and incubated in 30% sucrose in PBS until they sank. 30 µm 509 
slices were cut at the cryostat, and stored in PBS containing 0.02% NaN3 for 510 
future analysis. Brain sections were permeabilized at room temperature (RT) 511 
in 0.5% Triton X-100 (Sigma) for 1 hr RT, followed by 1 hr RT blocking in 2% 512 
BSA 0.5% Triton X-100 and overnight incubation with primary antibody (Iba1 513 
1:1000, Wako Chemicals, Cat. No. 019-19741 and CD68 1:400, Bio-Rad Cat. 514 
No. MCA19578) at 4°C. Upon washing, sections were incubated 2 hr RT with 515 
Alexa-fluorophore-conjugated secondary antibodies (Invitrogen), and 516 
counterstained with DAPI (Invitrogen).  517 
Confocal microscopy was performed with a TCS-SP5 (Leica) Laser Scanning 518 
System, by using a 20X dry objective and images were processed and 519 
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analyzed by Fiji Software or Imaris Software (Bitplane, Switzerland), as 520 
appropriate. Imaris was used for 3D rendering of confocal images for 521 
quantification of volumes. 522 
For density analysis, for each acquisition, the DAPI channel was max-523 
projected and the medial and lateral portions of the lateral habenula were 524 
manually drawn as region of interest. Then, stacks ranging from 15 to 20µm in 525 
thickness, with z-step size of 1µm, were processed as follows: Iba1 and DAPI 526 
channels were thresholded in Fiji and multiplied to each other for each stack, 527 
with the image calculator function. The resulting thresholded stack was max-528 
projected and the microglia nuclei were counted with Analyze Particle 529 
function.  530 
For cell soma size and Iba1 intensity, each acquisition was max-projected and 531 
the contour of cell somata in the medial portion of the lateral habenula were 532 
manually drawn based on the Iba1 immunoreactivity, and analyzed per size in 533 
µm2 and intensity. 534 
3D imaging analysis was performed by Imaris applying recorded algorithms 535 
(fixed thresholds for signal intensity) to all the images of the same experiment, 536 
in order to produce unbiased signal quantification. In each experiment, one 537 
brain slice per animal (n=4) per each group was acquired. The microglial cell 538 
volume and the volume of phagocytic structures were reconstructed based on 539 
the absolute intensity of Iba1 and CD68 signals, respectively. The volume of 540 
CD68 was then normalized for the Iba1 volume, to take in account the cell 541 
size.  542 
 543 
Behavior.  544 
Social preference test. A three-chambered social preference test was used, 545 
consisting in a rectangular Plexiglas arena (60 × 40 × 22 cm) (Ugo Basile, 546 
Varese, Italy) divided into three chambers. The walls of the center chamber 547 
had doors to allow free access to all compartments. The luminosity was 548 
around 10 lux. Thirty minutes after naloxone injection each mouse was placed 549 
in the arena for a habituation period of 10 min and was allowed to freely 550 
explore the whole empty arena. The social preference test was performed 551 
immediately after the end of the habituation: two enclosures with vertical bars 552 
were placed in the middle of the two lateral compartments, while the central 553 
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chamber remained empty. One enclosure was empty (serving as an 554 
inanimate object) whereas the other contained a social stimulus (unfamiliar 555 
juvenile mouse 25 ± 1 days old). The enclosures allowed visual, auditory, 556 
olfactory and tactile contact between the experimental mice and the social 557 
stimuli mice. The juvenile mice in the enclosures were habituated to the 558 
apparatus and the enclosures for 3 days before the experiment and each one 559 
of them served as a social stimulus for no more than 2 experimental mice (at 560 
least 6 weeks old). The test lasted 10 minutes where experimental mice were 561 
allowed to freely explore the apparatus and the enclosures. The position of 562 
the empty and juvenile-containing enclosures alternated and was 563 
counterbalanced for each trial to avoid any bias effects. Every session was 564 
video-tracked and recorded using Ethovision XT (Noldus, Wageningen, the 565 
Netherlands) or AnyMaze (Stoelting, Ireland), which provided an automated 566 
recording of the entries and time spent in the compartments, the distance 567 
moved and the velocity. The time spent in each chamber was assessed and 568 
then used to determine the preference score for the social compartment as 569 
compared to the object compartment (social/(social + object)). The arena was 570 
cleaned with 1% acetic acid solution and dried between trials. 571 
 572 
Analysis and statistics. Animals were randomly assigned to experimental 573 
groups. Compiled data are always reported and represented as whisker box 574 
plots (whisker top/bottom represent 90/10th percentile, box top/bottom 575 
represent 75/25th percentile and median) or mean ± SEM, with single data 576 
points plotted (single cell for electrophysiology and single animal for 577 
behavioral experiments). Animals or data points were not excluded unless 578 
stated and normality test was applied. Data collection and analysis were not 579 
performed blind to the conditions of the experiments. When applicable, 580 
statistical tests were paired or unpaired t-test and one-way or two-way 581 
ANOVA. Significance for correlations was obtained applying Pearson’s 582 
estimates.  Testing was always performed two-tailed with α = 0.05. More 583 
information on the methods and analysis can be found in the Life Science 584 
Reporting Summary. 585 
 586 
 587 
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Data availability statement 588 
The data sets generated during and/or analyzed during the current study are 589 
available from the corresponding author on reasonable request. 590 
 591 
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